Gender-based violence (GBV) is a serious international health problem that challenges fundamental human rights. In addition to violating fundamental rights, it is an attack on the principles of gender equality. GBV is exacerbated in situations of conflict and forced displacement because of the vulnerability it engenders, particularly among women and children. Therefore, caring for victims of GBV in the context of a humanitarian crisis is special because of the specific nature of the context itself. This study aimed to explore the factors that negatively influence the care of survivors of GBV in the context of forced displacement. This was a descriptive and analytical-qualitative study. A total of 26 participants participated in the individual interviews. Most participants were healthcare workers (53,8%). The findings show that barriers to care are sociocultural (fear of stigmatization, ignorance of the benefits of seeking appropriate care and support, self-censorship among GBV survivors, fear or risk of reprisal, honor denied, fear of the aggressor punishment, shame and fear of being repudiated), institutional (lack of qualified human resources to care for GBV survivors, insufficient information on the availability of care services, geographical inaccessibility of care services, lack of confidentiality from service providers, inadequate health care and support systems, low availability of care services, poor quality of care) and financial. Bringing all care services together in one place, such as a one-stop center, is imperative to overcome these obstacles. In this way, it will be possible to improve accessibility to services and enhance the quality of care through effective coordination.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Burkina Faso Health Research Ethics Committee approved the study protocol under number 2022-01-012 on January 17, 2022.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript